Client News
Filter by:
- Oct 21 2022 NetCents Technology Provides Cryptocurrency Merchant Gateway Technology Advancement Update
- Oct 21 2022 NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company
- Oct 20 2022 Profire Energy Sets Third Quarter 2022 Conference Call for Thursday, November 3, 2022 at 8:30 a.m. ET
- Oct 14 2022 NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing
- Oct 10 2022 Profire Energy Announces Preliminary Third Quarter 2022 Revenue Range of $12.5 to $12.7 Million
- Oct 5 2022 Profire Energy, Inc. to Present and Host Investor Meetings at Dawson James Securities 7th Annual Small Cap Growth Conference on October 12th
- Oct 3 2022 Adamis Announces Review of Strategic Alternatives
- Oct 3 2022 NetCents Technology Provides Update on the Status of the Audit of Its 2020 Financial Statements
- Sep 22 2022 NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference
- Sep 21 2022 Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects